89bio Announces Teresa Perney's Appointment as Chief Regulatory and Quality Officer
Monday, 16 September 2024, 14:09
89bio's New Appointment
89bio, Inc. has announced the appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer. Her extensive experience in regulatory affairs will play a crucial role in advancing the company's innovative therapies.
Impact on Clinical Development
Teresa Perney brings a wealth of knowledge to the team, which will enhance the clinical development strategies necessary for 89bio's commitment to improving patient outcomes in liver diseases. This appointment reflects the company’s ambition to lead in the biopharmaceutical sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.